Article
Management of Pulmonary Arterial Hypertension. Current Strategies and Future Prospects
2025-01-15
Abstract excerpt
Primary pulmonary hypertension (PPH), now known as pulmonary arterial hypertension (PAH), has envisioned significant treatment breakthroughs in the past decade. Treatment has focused on improving patient survival and quality of life and delaying disease progression. Current therapies are categorized based on targeting different pathways known to contribute to PAH, including endothelin receptor antagonists (ERAs),...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0aef5f8f-feb3-59b5-b557-f82882bfa5dc
- DOI
- 10.20944/preprints202501.1187.v1
